Senior insider sale
Chief Scientific Officer at AKERO THERAPEUTICS, INC. — senior position signals high conviction
$3.76M
81.37K shares
What this filing means
ROLPH TIMOTHY plans to sell 81.37K shares of AKERO THERAPEUTICS, INC. valued at approximately $3.76M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/7/2025ACC: 0001968582-25-000983
Officer· Chief Scientific Officer
Since Jun 2019
81.37K
Shares to sell
$3.76M
Approx. market value
56.37K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Compensation
10/7/2025
56.37KTotal acquired56.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/7/2025 | Stock Option Exercise Compensation | 56.37K | — |
| Total | 56.37K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
12.50K
Market value
$552.1K
9/8/2025
—Completed
Units to sell
12.50K
Market value
$616.3K
8/5/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
56.37K
Market value
$2.60M
10/7/2025
Total
Units
81.37K
Value
$3.76M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/8/2025 | 12.50K | $552.1K | — | Completed |
8/5/2025 | 12.50K | $616.3K | — | Completed |
| Planned — Approximate Date | ||||
10/7/2025 | 56.37K | $2.60M | NASDAQ | Planned |
| Total | 81.37K | $3.76M | ||